Advanced Search
Contact | Corporate | Help

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

Sponsors:
  • Ohio State University Comprehensive Cancer Center
  • Genentech
  • The Cleveland Clinic
  • University of Michigan
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Trastuzumab
  • Drug: Bevacizumab
  • Drug: Docetaxel
Enrollment:
39

Additional information about NCT00428922.


SourceSolution © 2008-2012